LifeNet Health Showcases Breakthrough MIS Technology at the 2022 NASS Annual Meeting
Oltnews,
The exhibition presents ViviGen® MIS, the first viable cellular allograft delivery system designed specifically for minimally…
The exhibition presents ViviGen® MIS, the first viable cellular allograft delivery system designed specifically for minimally…
The objective of this study was to retrospectively compare initial procedure and 12-month follow-up hospitalization charges and…